DoH releases primary care guidelines for vaccine blood clots The Department of Health document outlines possible presentations, symptoms and signs to look out for, as well as initial investigations.
Third death linked to AstraZeneca The recent death of a 61-year-old WA woman was likely linked to the vaccine, TGA confirms: ‘Lack of strong evidence for other causes.’
DoH confirms vaccine indemnity scheme, but questions remain ‘You shouldn’t fear that you’re going to get tied up in complicated litigation if something – despite your best efforts – goes wrong,’ the DoH First Assistant Secretary has told GPs.
National Cabinet announces no-fault indemnity scheme for GPs to administer AstraZeneca The move opens the door for under-60s to receive the vaccine as the country looks to speed up the rollout amid a potential national outbreak.
New AstraZeneca guidance reinforces need for vaccine counselling MBS numbers The decision to limit the use of AstraZeneca’s COVID vaccine to only people aged 60 and older will likely place more pressure on GPs dealing with vaccine-hesitant patients.
History of blood clots not usually a reason to avoid AstraZeneca Patients who have had blood clots or take blood thinners often ask these two haematologists, ‘Should I have the AstraZeneca vaccine?’
Identifying and treating vaccine-linked blood clots in general practice Other than age, there are ‘no known risk factors’ associated with developing blood clots with low platelets following an AstraZeneca vaccination, but GPs can still take steps to protect patients.
Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
Benefits of AstraZeneca overwhelmingly high despite increased clotting risk New European research has found the risk of a rare blood clotting syndrome associated with the vaccine is double what has been previously reported.
Are blood clots a concern with mRNA vaccines? An investigation into Australia’s first case of blood clotting after the Pfizer vaccine has yet to confirm a link.